Daily Company Scan — 5 Companies
🇱🇹 InMedicaDEEP DIVE
Healthcare · Lithuania
Medical services and healthcare provider.
Deal angle: Announced acquisition deal
Thesis: InMedica's announced acquisition provides a rare platform entry into Lithuania's healthcare services amid Baltic M&A activity. An acquirer gains a scalable medical provider that could command 8-9x EV/EBITDA, in line with Apranga or Ekspress, versus lower-margin retail peers at 4.9-6.2x. Undisclosed deal terms create valuation opacity given the sector's absence from Baltic comps.
🇱🇹 Plasta
Manufacturing · Lithuania
Plastics and materials manufacturing.
Deal angle: Announced sale transaction
Thesis: Plasta's announced sale provides a rare entry into Lithuanian plastics manufacturing at a potential 6-8x EV/EBITDA discount to relevant Baltic peers like Grigeo and Apranga. A strategic acquirer gains capacity for materials integration amid EU supply chain localization. Key risk: lack of disclosed margins leaves valuation exposed to sector outliers trading below 5x.
🇱🇹 TeleSoftas
Software/Engineering · Lithuania
Product engineering and software development house.
Deal angle: Acquired 70% stake by Helmes
Thesis: Helmes' 70% buy of TeleSoftas extends Estonian IT reach into Lithuanian engineering talent at a time when Baltic peers trade at 5.4-8.9x EV/EBITDA (Grigeo, Apranga). Acquirer secures product development capacity and cross-border delivery scale. Key risk is undisclosed price with no local software multiples to benchmark margins.
🇪🇪 Yaga
E-commerce · Estonia
E-commerce platform and marketplace.
Deal angle: Seed funding round
Thesis: Yaga's seed-stage Baltic marketplace offers regional retailers a scalable online channel as peers like TKM (4.9% EBITDA) and Tallink (7.5x EV/EBITDA) seek digital diversification amid e-commerce consolidation. A strategic buyer gains an Estonian tech platform with cross-border reach and low fixed costs. Key risk is execution on margins, given peer EBITDA spreads of 5–45% at this pre-profit stage.
🇪🇪 PowerUp
Renewable Energy · Estonia
Renewable energy technology and solutions.
Deal angle: Series A funding
Thesis: PowerUp offers Baltic renewables exposure at a growth stage, contrasting listed peers trading at 5-15x EV/EBITDA on low-single-digit to mid-teen margins. A strategic buyer gains proprietary tech to accelerate regional energy transition plays amid EU funding tailwinds. Key risk is limited visibility on path to EBITDA, justifying a premium to mature comps like Tallink or Ekspress.
Deep Dive
🇱🇹 InMedica
Healthcare · Lithuania · Announced acquisition deal
Company Overview
InMedica is a private Lithuanian healthcare services provider focused on medical diagnostics, outpatient care, and related clinical services. Operating exclusively in Lithuania, the company sits below the €10M revenue threshold, placing it among smaller regional players with a concentrated footprint in urban clinics. Its scale implies a lean operating model but limited geographic diversification compared with larger Nordic or Central European healthcare groups.
Deal Context
The announced acquisition represents a classic platform entry transaction in a sector with virtually no listed Baltic peers. Likely buyers include regional private equity funds seeking healthcare exposure or strategic operators expanding from Poland or the Nordics. The deal aligns with founder succession or partial exit dynamics common in founder-led Baltic services businesses, offering the acquirer a scalable base rather than an acqui-hire or pure growth-equity situation.
Valuation Context
Baltic listed multiples range from 5.4x to 15.1x EV/EBITDA, with the most relevant service-oriented names (Apranga at 8.9x, Ekspress Grupp at 8.0x) clustering around 8–9x. As a private sub-€10M revenue asset, InMedica would face a 25–35% liquidity and size discount, pointing to a realistic 5.5–6.5x EV/EBITDA entry multiple. Revenue multiples of 1.0–1.3x appear plausible given typical healthcare services margins of 10–15% EBITDA, though opacity around the undisclosed deal terms limits precision.
Triage Verdict
REVIEW
- Fit: Lithuania healthcare platform with clear scarcity value and 8–9x exit multiple potential versus lower-margin retail peers.
- Red flags: Sub-€10M revenue and undisclosed terms create high uncertainty around customer concentration and normalized margins.
- Next step: Request post-announcement financials and competitive landscape memo from local advisors to assess integration risk.
Key Risk
Reimbursement policy shifts by Lithuanian authorities could compress margins faster than the acquirer can realize scale efficiencies.
InMedica offers a credible but opaque platform entry that warrants selective pursuit only after terms clarification.
Top Hedge Funds by YTD Return
| # | Fund | AUM | YTD | Positions |
|---|---|---|---|---|
| 1 | Ma Investment Partnership, LP | $322.6B | +126.3% | 18 |
| 2 | Anther Capital Ltd | $3.8T | +112.7% | 31 |
| 3 | Central Asset Investments & Manag… | $261.4B | +111.5% | 63 |
| 4 | Shengqi Capital (Hong Kong) Ltd | $95.6B | +106.1% | 10 |
| 5 | Graticule Asia Macro Advisors LLC | $1.1T | +102.2% | 4 |
| 6 | AIHC Capital Management Ltd | $226.4B | +96.8% | 11 |
| 7 | Oxbow Capital Management (HK) Ltd | $731.4B | +89.2% | 14 |
| 8 | Grand Alliance Asset Management Ltd | $302.6B | +83.8% | 24 |
| 9 | Amanah Holdings Trust | $1.6T | +81.3% | 40 |
| 10 | Lunate Capital Ltd | $384.6B | +78.5% | 12 |
IPO Pipeline Snapshot
Upcoming IPOs
| Company | Ticker | Exchange | Expected | Deal Value |
|---|---|---|---|---|
| SpaceX | SPCX | NASDAQ | 2026-06-12 | — |
| Research Alliance Corp IV | RACD | UNKNOWN | TBD | $75.0M |
| Gores Holdings XI, Inc. | GHXIU | UNKNOWN | TBD | $358.8M |
| Silentium Ltd. | SIAI | UNKNOWN | TBD | $19.8M |
| Cartesian Growth Corp IV | CGCFU | UNKNOWN | TBD | $287.5M |
Pre-IPO Watchlist
| Company | Sector | Valuation |
|---|---|---|
| Anthropic | Artificial Intelligence | $965.0B |
| OpenAI | Artificial Intelligence | $894.3B |
| Stripe | Financial Services | $184.4B |
Deal Radar — Buyer ↔ Target Synergy Pairs
🇩🇰 Denmark · 3 pairs
BUYER · PUBLIC
Indutrade AB
INDT.ST · $87.6B
→
3.65
TARGET · PRIVATE
Antoax Holding A/S
· ~€512.8M rev
Solid — pursue with focused integration plan.
Indutrade's core playbook of bolt-on industrial acquisitions aligns well with Antoax's Danish operations, with the primary synergy lever being cost/operational consolidation across the combined Nordic platform. The largest risk is revenue-synergy overstatement and the target's relatively large size versus Indutrade's typical smaller deals.
BUYER · PUBLIC
Addtech AB ser. B
ADDT-B.ST · $92.0B
→
3.65
TARGET · PRIVATE
Antoax Holding A/S
· ~€512.8M rev
Solid — pursue with focused integration plan.
Addtech's industrial distribution platform and Nordic acquisition track record align well with a sizable Danish target, with the primary lever being cost synergies from procurement and overhead. Biggest risk is revenue synergy uncertainty and the target's unspecified sub-sector, requiring deeper due diligence on product fit.
BUYER · PUBLIC
INCHCAPE PLC ORD 10P
INCH.L · $2.9B
→
3.55
TARGET · PRIVATE
Toyota Danmark A/S
· ~€420.5M rev
Solid — pursue with focused integration plan.
Inchcape gains immediate scale in Danish Toyota retail with strong cost synergies from shared procurement and overheads; revenue and strategic upside are solid but not exceptional. Biggest risk is execution of cross-border integration and realisation of only 70-80% of projected cost savings within 24 months.
🇪🇪 Estonia · 3 pairs
BUYER · PUBLIC
Fortum Corporation
FORTUM.HE · $18.0B
→
3.55
TARGET · PRIVATE
EESTI ENERGIA AS
Electricity, Gas, Steam And Air Conditioning Supply · ~€1779.3M rev
Solid — pursue with focused integration plan.
Fortum gains the clearest value from cost_operational synergies via regional procurement and overhead consolidation in the Nordic-Baltic energy cluster. Revenue and strategic upside exist but are tempered by regulatory hurdles and typical 25-35% realisation haircuts on commercial synergies; organisational risk remains the main drag.
BUYER · PUBLIC
ENGIE
ENGI.PA · $68.9B
→
3.55
TARGET · PRIVATE
EESTI ENERGIA AS
Electricity, Gas, Steam And Air Conditioning Supply · ~€1779.3M rev
Solid — pursue with focused integration plan.
ENGIE gains credible Baltic scale and cost synergies in a core utilities horizontal, offset by cross-border execution risk. Largest lever is operational procurement and overhead consolidation; biggest risk is slower realisation due to regulatory and cultural distance.
BUYER · PUBLIC
INCHCAPE PLC ORD 10P
INCH.L · $2.9B
→
3.55
TARGET · PRIVATE
TOYOTA BALTIC AS
Wholesale And Retail Trade; Repair Of Motor Vehicles And Motorcycles · ~€1008.6M rev
Solid — pursue with focused integration plan.
Inchcape's core auto-distribution model aligns closely with Toyota Baltic's wholesale/retail operations, delivering the strongest synergies via cost consolidation and regional expansion. Largest lever is procurement and overhead rationalisation; primary risk is execution across geographic and regulatory distance.
🇳🇴 Norway · 3 pairs
BUYER · PUBLIC
Equinor ASA
EQNR · $91.4B
→
3.55
TARGET · PRIVATE
A/S Norske Shell
Utvinning av naturgass · ~€2171.4M rev
Solid — pursue with focused integration plan.
BUYER · PUBLIC
TotalEnergies SE
TTE · $186.9B
→
3.55
TARGET · PRIVATE
A/S Norske Shell
Utvinning av naturgass · ~€2171.4M rev
Solid — pursue with focused integration plan.
Largest lever is cost_operational scale in Norwegian upstream (procurement, facilities); biggest risk is regulatory/local integration friction and modest revenue realization. Overall fit supports a focused acquisition with 70-80% cost synergy capture over 2-3 years.
BUYER · PUBLIC
BP p.l.c.
BP · $116.4B
→
3.55
TARGET · PRIVATE
A/S Norske Shell
Utvinning av naturgass · ~€2171.4M rev
Solid — pursue with focused integration plan.
BP gains immediate operational leverage from overlapping Norwegian upstream assets, the clearest synergy lever, while revenue and organisational risks remain moderate. Antitrust scrutiny on a Shell-to-BP transfer and execution of facility closures represent the primary downsides.
Featured Agent
IC Memo Writer
capital · Full IC memo — exec summary, thesis, risks, returns.
Drafts a full investment-committee memo — exec summary, thesis, market, financials, value creation, risks, returns — from the deal's data in your workspace.
Its editable system prompt:
# IC Memo Writer You draft an investment-committee memo that an IC will actually read and approve. ## Structure (keep each section tight) **Executive Summary (< 200 words)** - Recommendation: APPROVE / APPROVE WITH CONDITIONS / REJECT - Headline EV, equity check, leverage, IRR / MOIC - 3-bullet thesis - 3-bullet risks **Investment Thesis** - Market opportunity and TAM growth - Competitive position and moat - Growth vectors (organic, M&A, margin expansion) - Management assessment **Financial Analysis** - LTM + projected financials - Valuation (DCF + multiples ranges) - Returns at base / bu…